This company has been marked as potentially delisted and may not be actively trading. Longview Acquisition Corp. II (LGV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LGV vs. TMO, ISRG, IDXX, EW, ALC, IQV, MTD, DXCM, STE, and WATShould you be buying Longview Acquisition Corp. II stock or one of its competitors? The main competitors of Longview Acquisition Corp. II include Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), Alcon (ALC), IQVIA (IQV), Mettler-Toledo International (MTD), DexCom (DXCM), STERIS (STE), and Waters (WAT). These companies are all part of the "med instruments" industry. Longview Acquisition Corp. II vs. Its Competitors Thermo Fisher Scientific Intuitive Surgical IDEXX Laboratories Edwards Lifesciences Alcon IQVIA Mettler-Toledo International DexCom STERIS Waters Longview Acquisition Corp. II (NYSE:LGV) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation. Which has preferable earnings and valuation, LGV or TMO? Thermo Fisher Scientific has higher revenue and earnings than Longview Acquisition Corp. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongview Acquisition Corp. IIN/AN/AN/AN/AN/AThermo Fisher Scientific$42.88B5.01$6.34B$17.2932.88 Is LGV or TMO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to Longview Acquisition Corp. II's net margin of 0.00%. Thermo Fisher Scientific's return on equity of 16.82% beat Longview Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Longview Acquisition Corp. IIN/A N/A N/A Thermo Fisher Scientific 15.24%16.82%8.38% Do insiders and institutionals have more ownership in LGV or TMO? 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 26.4% of Longview Acquisition Corp. II shares are owned by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to LGV or TMO? In the previous week, Thermo Fisher Scientific had 75 more articles in the media than Longview Acquisition Corp. II. MarketBeat recorded 75 mentions for Thermo Fisher Scientific and 0 mentions for Longview Acquisition Corp. II. Thermo Fisher Scientific's average media sentiment score of 1.15 beat Longview Acquisition Corp. II's score of 0.00 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Overall Sentiment Longview Acquisition Corp. II Neutral Thermo Fisher Scientific Positive Do analysts rate LGV or TMO? Thermo Fisher Scientific has a consensus target price of $581.63, suggesting a potential upside of 2.32%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Longview Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longview Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.76 SummaryThermo Fisher Scientific beats Longview Acquisition Corp. II on 10 of the 11 factors compared between the two stocks. Get Longview Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for LGV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LGV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGV vs. The Competition Export to ExcelMetricLongview Acquisition Corp. IIMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$7.31B$6.18B$21.97BDividend YieldN/A1.14%5.72%3.60%P/E RatioN/A27.2629.0932.44Price / SalesN/A27.68584.2759.12Price / CashN/A22.2737.1224.33Price / BookN/A5.2312.244.60Net IncomeN/A$178.09M$3.33B$1.02B Longview Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGVLongview Acquisition Corp. IIN/A$10.09flatN/AN/A$0.00N/A0.003High Trading VolumeTMOThermo Fisher Scientific4.5943 of 5 stars$528.22+0.7%$593.43+12.3%-6.0%$199.41B$42.88B30.54125,000Trending NewsEarnings ReportAnalyst ForecastISRGIntuitive Surgical4.561 of 5 stars$437.33+1.8%$584.76+33.7%-10.8%$156.84B$9.15B61.0215,638Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑Gap UpIDXXIDEXX Laboratories4.4644 of 5 stars$632.33+2.6%$656.50+3.8%+40.5%$50.59B$3.90B52.6511,000Positive NewsEWEdwards Lifesciences4.5753 of 5 stars$73.24-0.9%$87.06+18.9%+8.5%$43.01B$5.69B10.5415,800Positive NewsUpcoming EarningsOptions VolumeALCAlcon3.8132 of 5 stars$72.85+1.1%$93.41+28.2%-19.7%$35.98B$9.91B33.9325,599Analyst ForecastIQVIQVIA4.5149 of 5 stars$206.04+4.0%$236.45+14.8%-5.3%$35.03B$15.70B29.8288,000Upcoming EarningsMTDMettler-Toledo International4.087 of 5 stars$1,294.89+1.7%$1,336.50+3.2%+1.5%$26.67B$3.87B32.7917,300Positive NewsDXCMDexCom4.8201 of 5 stars$65.73+0.9%$97.42+48.2%-3.9%$25.80B$4.03B45.6910,300Analyst ForecastSTESTERIS4.7805 of 5 stars$236.60+0.3%$273.50+15.6%+7.8%$23.30B$5.46B36.2317,787Positive NewsAnalyst RevisionWATWaters4.1127 of 5 stars$334.59+1.1%$377.56+12.8%+1.2%$19.91B$2.96B30.167,600Trending News Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors Intuitive Surgical Competitors IDEXX Laboratories Competitors Edwards Lifesciences Competitors Alcon Competitors IQVIA Competitors Mettler-Toledo International Competitors DexCom Competitors STERIS Competitors Waters Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LGV) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredBitcoin is dead?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longview Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Longview Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGV Stock Alerts